Mайкролакс (Sorbitol, Liquid (Crystallising), Sodium Citrate, Sodium Lauryl Sulfoacetate 70%)

Mайкролакс is a rectally administered laxative that acts on the lower gastrointestinal tract to alleviate constipation.

• Constipation: softens stool and stimulates rectal evacuation, providing relief of infrequent bowel movements.
• Bowel preparation: assists in clearing the colon before diagnostic procedures such as colonoscopy.
• Occasional constipation in adults: offers rapid, over‑the‑counter relief without systemic absorption.

• Each component contributes to an osmotic and surfactant effect. Sorbitol draws water into the intestinal lumen, increasing stool volume. Sodium citrate raises the pH, enhancing fluid retention. Sodium Lauryl Sulfoacetate reduces surface tension of intestinal contents, promoting mixing of water and feces, which together facilitate softer stools and easier passage. The combined action results in a localized laxative effect without significant systemic absorption, making it suitable for short‑term use.

Mайкролакс may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Abdominal cramping: mild discomfort in the lower abdomen.
• Flatulence: increased intestinal gas.
• Mild diarrhea: loose stools occurring shortly after use.
• Rectal irritation: transient burning or itching at the application site.
• Nausea: occasional feeling of queasiness.
• Urgency to defecate: sudden need to pass stool.

Serious or Rare Side Effects

• Severe electrolyte imbalance: abnormal blood sodium or potassium levels.
• Allergic reaction: rash, swelling, or difficulty breathing.
• Severe abdominal pain: intense, persistent pain requiring medical attention.
• Rectal bleeding: presence of blood in stool or on toilet paper.
• Dehydration: excessive fluid loss leading to dizziness or weakness.

Before using Mайкролакс, consider the following precautions to ensure safe and effective use.

• Assess severity of constipation: confirm that symptoms are mild to moderate and suitable for an over‑the‑counter laxative.
• Avoid in intestinal obstruction: do not use if there is known blockage or severe abdominal pain.
• Use cautiously with inflammatory bowel disease: patients with Crohn’s disease or ulcerative colitis should consult a healthcare professional.
• Do not exceed recommended frequency: limit applications to the dosage instructions provided by the prescriber.
• Monitor fluid intake: maintain adequate hydration to reduce risk of dehydration.
• Store at ambient temperature: keep the product in its original container, protect from moisture and direct sunlight.

Mайкролакс can interact with other medicines; awareness of these interactions helps prevent adverse outcomes.

Major Interactions (Avoid)

• Concurrent osmotic laxatives: combined use may cause severe electrolyte disturbances.
• Anticholinergic agents: may reduce the laxative effect and increase constipation risk.
• Dehydrating medications: such as diuretics, can amplify fluid loss.

Moderate Interactions (Monitor Closely)

• Diuretics: monitor electrolyte balance and hydration status.
• Mineral supplements (calcium, magnesium): may alter stool consistency.
• Oral anticoagulants: rare risk of increased rectal bleeding; observe for signs of bleeding.